Login / Signup

A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.

Abbas TaherMarjan LashgariLadan SedighiFarshid Rahimi-BasharJalal PoorolajalMaryam Mehrpooya
Published in: Pharmacological reports : PR (2021)
The trial was registered at Clinicaltrials.gov (identifier code: IRCT20120215009014N355). Registration date: 2020-05-18.
Keyphrases
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • mechanical ventilation
  • coronavirus disease
  • sars cov
  • clinical trial
  • high dose
  • phase iii
  • randomized controlled trial
  • replacement therapy